EyePoint Pharmaceuticals's market cap is currently $446.36M. The company's EPS TTM is $-2.006; its P/E ratio is ―; EyePoint Pharmaceuticals is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-0.49. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 46.02M	$ 41.40M	$ 36.94M	$ 34.44M	$ 20.36M
Gross Profit	$ 41.39M	$ 33.08M	$ 28.76M	$ 28.61M	$ 17.68M
Operating Income	$ -75.07M	$ -78.94M	$ -55.28M	$ -37.29M	$ -47.86M
EBITDA	$ -69.00M	$ -96.62M	$ -50.15M	$ -35.49M	$ -48.01M
Net Income	$ -70.80M	$ -124.51M	$ -63.91M	$ -52.65M	$ -62.97M
Balance Sheet
Cash & Short-Term Investments	$ 331.05M	$ 144.56M	$ 211.56M	$ 44.91M	$ 22.21M
Total Assets	$ 355.18M	$ 180.36M	$ 263.37M	$ 91.72M	$ 73.32M
Total Debt	$ 4.91M	$ 45.77M	$ 38.42M	$ 40.31M	$ 50.60M
Net Debt	$ -276.36M	$ -49.86M	$ -140.17M	$ -4.60M	$ 28.39M
Total Liabilities	$ 88.86M	$ 83.99M	$ 78.99M	$ 73.18M	$ 64.99M
Stockholders' Equity	$ 266.32M	$ 96.37M	$ 184.38M	$ 18.54M	$ 8.33M
Cash Flow
Free Cash Flow	$ -1.61M	$ -67.16M	$ -50.25M	$ -14.80M	$ -56.91M
Operating Cash Flow	$ 1.88M	$ -65.00M	$ -50.10M	$ -14.44M	$ -56.70M
Investing Cash Flow	$ -3.31M	$ -17.27M	$ -33.12M	$ -362.00K	$ -213.00K
Financing Cash Flow	$ 187.07M	$ -690.00K	$ 216.90M	$ 37.49M	$ 33.86M

Currency in USD

EyePoint Pharmaceuticals Earnings and Revenue History

Income Statement >

EyePoint Pharmaceuticals Debt to Assets

Balance Sheet >

EyePoint Pharmaceuticals Cash Flow

Cash Flow >

EyePoint Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing